| Effect | Decrease |
| Values | DSM-IV Self-rating scale. Mean + SD. Total severity: Placebo: before 106.06 ± 44.12, after 91.60 ± 43.56. Curcumin: before 102.06 ± 39.64, after 42.47 ± 16.37. |
| Trial Design | Randomized trial |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 70 |
| Gender | Female |
In a randomized, double-blind, placebo-controlled trial, 70 women with premenstrual syndrome were allocated to take 200 mg of curcumin per day or placebo for 7 days before and 3 days after the onset of menstrual bleeding for 3 menstrual cycles.
There was a quite notable and statistically significant improvement in total severity of PMS, and each of physical, behavioral, and mood symptoms separately in the curcumin group.
